MUC5B Mutation May Lengthen Life for IPF Patients on Anti-fibrotics

MUC5B Mutation May Lengthen Life for IPF Patients on Anti-fibrotics

292433

MUC5B Mutation May Lengthen Life for IPF Patients on Anti-fibrotics

A variant of the MUC5B gene, known as the rs35705950 (T) allele, appears to lead to better survival in people with idiopathic pulmonary fibrosis (IPF) on anti-fibrotic treatment, a study reports. These findings highlight the potential usefulness of MUC5B genetic data in treating and managing these patients. The study, “Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment,” was published in Respiratory Research. Although the causes of IPF…

You must be logged in to read/download the full post.